Most Backed Boston, MA Startups 2026

12 Boston, MA startups ranked by number of verified backers, led by Scorpion Therapeutics, Seaport Therapeutics, Bambusa Therapeutics.

Boston, MA accounts for 120 tracked companies with verified cap-table data, 120 of which disclose round sizes totalling $44B. The median disclosed raise is $241M, and the largest is Dana-Farber Cancer Institute at $2.5B, ahead of Plymouth Industrial REIT ($2.1B) and Kailera Therapeutics ($1.6B).

The names that recur most often on these boston, ma cap tables are Andreessen Horowitz (6 companies), Atlas Venture (5 companies), BlackRock (4 companies), SoftBank (4 companies), Warburg Pincus (4 companies), General Catalyst (4 companies). By latest disclosed round, the market skews Series C (22), Series B (19), Growth (14), Series A (14).

Best funded Boston, MA companies

  1. Dana-Farber Cancer Institute — $2.5B
  2. Plymouth Industrial REIT — $2.1B (latest: IPO)
  3. Kailera Therapeutics — $1.6B (latest: IPO)
  4. Klaviyo — $1.5B (latest: IPO)
  5. Nexamp — $1.2B (latest: Growth)
  6. Thrasio — $1B (latest: Series D)
  7. Rhythm Pharmaceuticals — $1B (latest: IPO)
  8. Thumbtack — $926M (latest: Growth)
  9. Perch — $908M (latest: Series A)
  10. Lendbuzz — $890M (latest: Series C)
  11. Odyssey Therapeutics — $726M (latest: Series D)
  12. Ginkgo Bioworks — $719M (latest: Series E)
  13. Astria Therapeutics — $700M (latest: Growth)
  14. Aura Company — $650M (latest: Series F)
  15. Nimbus Therapeutics — $600M (latest: Series B)

More Boston MA research (1)

Research on comparable markets (18)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library